← Leaderboards
David Pickar
Gabriel Pharma, Llc
$1,304,000
Attributed
$1,304,000
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,304,000 · 3
By mechanism
R44$954,000 · 1
R43$350,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antipsychotic Agents”
- P Jeffrey Conn · Vanderbilt University$24,634,463
- Abraham Aizer Brody · New York University School Of Medicine$22,358,187
- Constantine G Lyketsos · Johns Hopkins University$14,554,427
- John H Krystal · Yale University$14,263,729
- Dilip V Jeste · University Of California San Diego$13,885,388
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$12,935,020
Research focus
Antipsychotic AgentsClozapinePsychopharmacologySchizophreniaGenetic ScreeningClinical ResearchHuman SubjectPharmacogeneticsTherapy Design /DevelopmentCatechol MethyltransferaseDopamineMental Health Information SystemChemical Information SystemBehavioral SensitizationCentral Nervous SystemCell LineBaseAnimals, LaboratoryDrug Adverse EffectDopamine TransporterDopamine ReceptorDrug MetabolismEnantiomerCardiac
Grant awards (4)
SBIR Triple Re-Uptake Inhibitors: Potential Antidepressants$250,000
R43 · FY2007 · MH · contact PI
Genetic Screen for Antipsychotic Drug Response$477,000
R44 · FY2005 · MH
Genetic Screen for Antipsychotic Drug Response$477,000
R44 · FY2004 · MH
Genetic Screen for Antipsychotic Drug Response$100,000
R43 · FY2002 · MH